Sinemet and Zosyn drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sinemet (carbidopa; levodopa) and Zosyn (piperacillin sodium; tazobactam sodium). Common drug interactions include anaemia haemolytic autoimmune among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Sinemet and Zosyn. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Sinemet?
Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.
What is Zosyn?
Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.
16 people who take Sinemet and Zosyn together, and have interactions are studied.

What are the common drug interactions of Sinemet and Zosyn, by gender? *:
female:
- Anaemia haemolytic autoimmune (a condition in which the immune system attacks the red blood cells, resulting in fewer of these oxygen-transporting cells)
- Chronic kidney disease
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Lactic acidosis (low ph in body tissues)
- Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
- Renal failure (kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Tonic clonic movements (generalized seizure that affects the entire brain)
- Unresponsive to stimuli
male:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- International normalised ratio increased
- Hepatic failure (liver failure)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hypotension (abnormally low blood pressure)
- Multi-organ failure (multisystem organ failure)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Pulmonary oedema (fluid accumulation in the lungs)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Subcutaneous abscess
What are the common drug interactions of Sinemet and Zosyn, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Chronic kidney disease
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Renal failure (kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Subcutaneous abscess
60+:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Hepatic failure (liver failure)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hypotension (abnormally low blood pressure)
- Lactic acidosis (low ph in body tissues)
- Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
- Multi-organ failure (multisystem organ failure)
What are the existing conditions these people have? *
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 37.50%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 12.50%
- High Blood Cholesterol: 2 people, 12.50%
- Diabetes: 2 people, 12.50%
- Weight Decreased: 1 person, 6.25%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.25%
- Anaemia (lack of blood): 1 person, 6.25%
- Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 1 person, 6.25%
- Blood Glucose Fluctuation: 1 person, 6.25%
- Blood Pressure Abnormal: 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Sinemet and Zosyn?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Sinemet and Zosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sinemet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sinemet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zosyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on carbidopa; levodopa and piperacillin sodium; tazobactam sodium (the active ingredients of Sinemet and Zosyn, respectively), and Sinemet and Zosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lorazepam and Prometrium - 15 seconds ago
- Drug interactions of Boniva and Ampyra - 30 seconds ago
- Could Carafate cause Oedema? - 33 seconds ago
- Could Capecitabine cause Oedema? - 42 seconds ago
- Could Cabometyx cause Oedema? - 44 seconds ago
- Could Camptosar cause Oedema? - 45 seconds ago
- Could Calquence cause Oedema? - 45 seconds ago
- Could Carpine cause Oedema? - 46 seconds ago
- Could Calcijex cause Oedema? - 46 seconds ago
- Could Xarelto cause Tumor Lysis Syndrome? - 47 seconds ago